Cost of care for elderly cancer patients in the United States.
about
Bending the Cost Curve in Cancer CareOpportunities to maximize value with integrated palliative careUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionEstimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyThe Business Case for Palliative Care: Translating Research Into Program Development in the U.S.The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.Cost of care for cancer patients in England: evidence from population-based patient-level data.Using big data for quality assessment in oncology.Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data.Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)Personalized therapy for metastatic melanoma: could timing be everything?Individualizing colonoscopy screening by sex and race.Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults.CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategiesBenefits, harms, and costs for breast cancer screening after US implementation of digital mammography.At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysisAdvanced imaging among health maintenance organization enrollees with cancerIncreasing use of advanced radiation therapy technologies in the last 30 days of life among patients dying as a result of cancer in the United States.Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromesShould colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysisComparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations.Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survivalHospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).The out of pocket cost of breast cancer survivors: a review.Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare populationHealthcare costs in patients with metastatic lung cancer receiving chemotherapy.Cost-effectiveness of colonoscopyCost-effectiveness of colorectal cancer screening - an overview.Evolution of breast cancer screening in the Medicare population: clinical and economic implications.Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosisUsing stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.Cost trend analysis of initial cancer treatment in Taiwan.Hospital-activity data inaccurate for determining spread-of-disease at diagnosis for non-small cell lung cancer.A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding.
P2860
Q22248106-7C00B3C8-9958-42AA-8AAF-5EB1C6223918Q26745944-7DE84218-28E3-445C-B801-94F0A58E5102Q28388931-38405D99-D936-4771-96F8-12CBA4D9BD48Q28539886-413E6B01-617A-4129-A351-1C668A92AF14Q30378215-C2F751A5-B86E-4897-ADAA-BE3D82A97739Q30749009-039FD5DA-E39C-46C2-A66E-0B710DFBEF20Q30885191-3F6F7234-6430-4FB4-BABC-ABCF22250047Q31075231-7A2E71B2-3326-4B90-8F99-26E34012F328Q31080159-8A2A35D5-94F6-4625-A8BA-A1B709A9892BQ31142213-6F1C20A1-0654-479D-87E8-209AFBC1AAD1Q33434251-1B3714D9-E1B7-4D56-8088-B10767FBBBA0Q33470183-F26F08B5-5DDF-4C2E-B164-A7CDC9A59341Q33481311-D9C7F776-3D3A-4AB7-AE02-5C4CA87271B4Q33559123-C5FD2A95-DB17-44BD-A188-C1F7267F5AABQ33576035-6468683E-781C-4846-A752-23A0C98B978BQ33588581-8D9297CD-537D-4EE1-9CDC-032DA90AC740Q33636436-A59D74E4-14F7-4609-A960-B32D32B26CBDQ33768335-A13D614E-3DC0-4CF7-8C25-2FE2D6E40C70Q33792616-B5850FB8-00B7-44CD-BD83-AA9446F2B176Q33810469-FDFE6752-BBCD-4E26-BC26-59A53E4AEF46Q33871791-0B01AA3C-F98B-4197-96F2-82833C548E94Q33890471-74CD874B-268E-4E84-BE46-2CC3C1F13FADQ33890507-CCB6D38E-9028-4D1D-98E4-36F4C36EB487Q33902455-F092C46A-8D6A-42A2-93A8-2A8886C4325FQ33942396-02E3D836-7C5F-4643-BCDC-B0DCA70DE273Q33981053-D7E487EF-00B8-489C-8CF9-CF13DC86A340Q33987025-1D261BDE-9078-41A4-B6D2-4A2C4BAC80F4Q33992552-6B7979C6-9E6C-4218-B9F1-88AA5097145DQ34069038-66601F66-26AF-4841-9F76-746F9ABF138DQ34071763-D42D5578-3DFB-44EF-AC92-E2E66071DDAEQ34072092-6BB6B5A1-3021-4445-8F65-1531788579A5Q34094196-C14A1267-6F6C-44B0-BEF0-2B5F837EAD81Q34125840-0762A765-2CDB-4C7B-AC1E-E44EB2CD0D1EQ34137696-E7E1CBAF-BC1C-4EF3-BCDD-EC91011F3682Q34157164-B977F7B9-20C0-4EE9-922C-28847A2BEBEFQ34201988-5EFBDA9B-4CDF-487B-9463-49ACCD4CAB0BQ34277478-C6B500E3-0262-4B7E-A4C4-8702D88AC0DFQ34287083-DDFF72F0-511F-40F4-82E0-BB79255ACC5FQ34294069-2293C326-9507-4643-882B-A3107A6B824EQ34338677-0137C3EC-1770-482A-87CD-44F5D3C6F771
P2860
Cost of care for elderly cancer patients in the United States.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Cost of care for elderly cancer patients in the United States.
@en
Cost of care for elderly cancer patients in the United States.
@nl
type
label
Cost of care for elderly cancer patients in the United States.
@en
Cost of care for elderly cancer patients in the United States.
@nl
prefLabel
Cost of care for elderly cancer patients in the United States.
@en
Cost of care for elderly cancer patients in the United States.
@nl
P2093
P2860
P356
P1476
Cost of care for elderly cancer patients in the United States
@en
P2093
Angela Mariotto
Angela Meekins
Elizabeth B Lamont
Joan L Warren
Marie Topor
Martin L Brown
P2860
P304
P356
10.1093/JNCI/DJN103
P407
P50
P577
2008-04-29T00:00:00Z